- Market Value (2025): USD 146.7 Mn
- Estimated Value (2026): USD 160.0 Mn
- Forecast Value (2036): USD 382.3 Mn
- CAGR (2026-2036): 9.1%
Clean-Label Medical Nutrition Bases Market Forecast and Outlook 2026 to 2036
The clean-label medical nutrition bases market is anticipated to expand from USD 160.0 million in 2026 to USD 382.3 million by 2036. Demand for clean-label medical nutrition bases is forecast to record a CAGR of 9.1% over the forecast period.
Demand is increasing as makers of oral nutritional supplements, tube feeds and disease-specific formulas respond to patients and dietitians who want products built on recognizable proteins, carbohydrates and fibers, without artificial sweeteners, colors, carrageenan or long additive lists. Nutrition ingredient suppliers are offering pre-formulated carbohydrate-protein, dairy, plant and fiber-fortified bases that manufacturers finish with vitamins, minerals and flavor. For example, in May 2026, FrieslandCampina announced an investment programme of more than EUR 90 million in high-value whey proteins for medical and specialized nutrition.
Market Highlights for the Clean-Label Medical Nutrition Bases Market
- Sales of clean-label medical nutrition bases stood at USD 146.7 million in 2025
- Clean-Label Medical Nutrition Bases Market Value (2026): USD 160.0 million
- Clean-Label Medical Nutrition Bases Market Forecast Value (2036): USD 382.3 million
- Clean-Label Medical Nutrition Bases Market Forecast CAGR (2026-2036): 9.1%
- Leading Product Type: Carbohydrate-protein base (22.7%)
- Key Market Participants: Nestlé Health Science, Abbott, Danone Nutricia, Fresenius Kabi, Arla Foods Ingredients, FrieslandCampina Ingredients
- Key Growth Regions: Netherlands, United States, Germany, France, United Kingdom
In October 2026, Abbott announced plans to separate its nutrition business into a publicly traded company. Danone reported 4.7% like-for-like growth in global Specialized Nutrition sales during the third quarter, supported by a 0.9% increase in volume/mix. European Specialized Nutrition recorded weaker volume/mix performance during the period. Medical nutrition manufacturers are refining their product portfolios and ingredient formulations to meet changing nutritional requirements.
Clean-Label Medical Nutrition Bases Market
| Metric | Value |
|---|---|
| Estimated Value in (2026) | USD 160.0 million |
| Forecast Value in (2036) | USD 382.3 million |
| Forecast CAGR (2026 to 2036) | 9.1% |
Source: Fact.MR analysis. Updated Nov 21, 2026
Source: Fact.MR analysis.

Clean Label Medical Nutrition Bases Forecast Global | Source: Fact.MR
Category
| Category | Segments |
|---|---|
| Product Type | Carbohydrate-protein base, Modular clinical nutrition base, Plant-based medical base, Dairy-based medical base, Fiber-fortified base |
| Delivery Form | Liquid, Specialty controlled-release, Tablet and capsule, Powder, Medical device and system |
| Clinical Use | Specialty and rare condition, Long-term management, Nutrition support, Preventive care, Acute care |
| Region | Netherlands; United States; Germany; France; United Kingdom |
Source: Fact.MR analysis. Updated Nov 21, 2026
Source: Fact.MR analysis.
Segmental Analysis
Why do carbohydrate-protein bases lead product demand in the Clean-Label Medical Nutrition Bases Market?

Clean Label Medical Nutrition Bases Breakdown Product Type | Source: Fact.MR
Carbohydrate-protein bases hold 22.7% of the clean-label medical nutrition bases market in 2026, valued at USD 36.3 million, because medical nutrition formulas require balanced energy and protein content to support patients with specific dietary needs. In 2025, Fresenius Kabi introduced its Diben 2 KCAL Drink range, offering high-protein nutrition with a modified carbohydrate profile for patients requiring nutritional support. Ingredient developers are refining protein blends and carbohydrate sources to improve taste, digestibility and product stability.
How is the liquid form leading demand in the Clean-Label Medical Nutrition Bases Market?

Clean Label Medical Nutrition Bases Breakdown Delivery Form | Source: Fact.MR
Liquid formulations account for 28.6% of clean-label medical nutrition bases revenue in 2026, generating USD 45.8 million, as ready-to-drink supplements and enteral feeds offer convenient administration in hospitals and homecare settings. In September 2026, Fresenius expanded its medical nutrition portfolio with NutriChef, a real-food-based enteral nutrition product containing fruits, vegetables and dietary fiber. Liquid nutrition manufacturers are working to maintain suitable texture and nutrient stability throughout processing.
Why do specialty and rare conditions lead clinical demand in the Clean-Label Medical Nutrition Bases Market?

Clean Label Medical Nutrition Bases Breakdown Clinical Use | Source: Fact.MR
Specialty and rare conditions represent 28.1% of clean-label medical nutrition bases revenue in 2026, equivalent to USD 45.0 million, because patients with inherited metabolic disorders, food allergies and certain neurological conditions require carefully formulated nutritional products. A February 2026 study published in Intractable & Rare Diseases Research examined foods for special medical purposes used in rare disease management, including protein substitutes, specialized dietary products and ketogenic formulations.
Clean-Label Medical Nutrition Bases Market-Drivers, Restraints & Trends
Drivers
Demand is increasing as research supports food-based formulas. For example, in October 2026, Clinical Nutrition ESPEN reported that food-based enteral formulas are increasingly used for children with medical complexity and are associated with improved feeding tolerance, and in August 2026 Danone described an enteral blend made mostly from soy and pea protein.
Restraints
Demand for clean-label medical nutrition bases is constrained by strict compositional rules, sterilization demands and raw material costs. For example, Glanbia reported in November 2026 that whey inflation raised its third-quarter pricing by about 26% and expected higher whey costs in early 2027.
Trend
Specialized Proteins for Medical Use Demand for heat-stable, low-lactose and hydrolyzed proteins is rising in clean-label recipes. Suppliers are investing in dedicated lines. Arla Foods Ingredients invested EUR 8.3 million at its Danmark Protein site in August 2026, and Fonterra completed a protein hub in 2026.
Trend
Plant-Based Medical Nutrition In September 2026, a study reported tolerance of tube feeds reformulated with a plant-dominant protein blend in adults on long-term support. Demand for soy- and pea-based medical bases is rising.
Clean-Label Medical Nutrition Bases Market by Analysis by Key Country

Clean Label Medical Nutrition Bases Growth Index | Source: Fact.MR
| Country | CAGR (2026-2036) |
|---|---|
| Netherlands | 9.9% |
| United States | 9.6% |
| Germany | 8.5% |
| France | 7.2% |
| United Kingdom | 6.9% |
Source: Fact.MR analysis. Updated Nov 21, 2026
Source: Fact.MR analysis.
What is driving clean-label medical nutrition bases demand in the Netherlands?
In May 2026, FrieslandCampina announced more than EUR 90 million of investment in whey proteins at Dutch sites, and Danone's Nutricia research center in Utrecht published work on plant-protein tube feeds in August.
Demand for clean-label medical nutrition bases in the Netherlands is projected to grow at a 9.9% CAGR, the fastest among the five key countries, as the country is a global center for medical nutrition development and production.
How is industry change supporting clean-label medical nutrition bases sales in the United States?
Sales of clean-label medical nutrition bases in the United States are projected to grow at a 9.6% CAGR as brands reformulate.
Abbott announced a nutrition spin-off in October 2026, and federal agencies advanced a proposed definition of ultra-processed foods in August 2026. Base manufacturers are helping U.S. companies simplify ingredient lists.
What is shaping clean-label medical nutrition bases demand in Germany?
Demand for clean-label medical nutrition bases in Germany is projected to grow at an 8.5% CAGR as hospital and homecare nutrition suppliers update ranges.
Germany is home to Fresenius Kabi, and its plant-based retail market is the largest in Europe. Nutrition ingredient suppliers are supplying German manufacturers of sip feeds and tube feeds.
How specialized nutrition shaping clean-label medical nutrition is bases sales in France?
Sales of clean-label medical nutrition bases in France are projected to grow at a 7.2% CAGR as Danone and Lactalis develop specialized nutrition. Danone reported third-quarter 2026 sales of EUR 7,233 million, representing 4.0% like-for-like growth.
Global Specialized Nutrition volume/mix increased by 0.9%, while the European business recorded weaker volume/mix performance. Medical nutrition producers are serving French medical nutrition plants.
Why is growth slower for clean-label medical nutrition bases in the United Kingdom?
Demand for clean-label medical nutrition bases in the United Kingdom is projected to grow at a 6.9% CAGR, the slowest among the five countries, as NHS bodies promote food-first approaches and tight prescribing of oral nutritional supplements.
Several integrated care boards issued prescribing guides in 2026. Formulation specialists are focusing on cost-effective powders.
Competitive Landscape for Clean-Label Medical Nutrition Bases Market
Medical nutrition companies are refining their ingredient portfolios to meet growing demand for specialized and simpler formulations. Nestlé Health Science, Abbott, Danone Nutricia and Fresenius Kabi develop nutritional products for patients with specific dietary requirements. Arla Foods Ingredients and FrieslandCampina Ingredients contribute through specialized dairy proteins and functional nutrition ingredients. Their offerings differ in protein quality, formulation stability, nutritional composition and ingredient processing. Manufacturers assess these factors alongside allergen management, regulatory compliance, taste and production costs when selecting nutrition bases.
Investment in high-quality proteins and changes in medical nutrition portfolios are reshaping supplier strategies. In October 2026, Abbott announced plans to separate its Nutrition business into an independent publicly traded company. Danone reported 3.7% like-for-like growth in Specialized Nutrition during the first nine months of 2026. FrieslandCampina Ingredients doubled its whey protein isolate and milk fat globule membrane production capacity at its Borculo facility in March 2026. These developments reflect continued attention to specialized nutrition and ingredient availability. Suppliers offering heat-stable proteins, consistent nutritional quality and simpler ingredient formulations will have opportunities to strengthen relationships with medical nutrition manufacturers.
Recent Developments
- In March 2026, Nestlé Health Science introduced Compleat Paediatric Oral Blends, featuring fruit-based ingredients, pea and rice proteins, vitamins, and minerals to provide complete medical nutrition for children requiring specialized nutritional support.
- In November 2025, Abbott introduced an advanced Ensure Diabetes Care formulation featuring slow-digesting carbohydrates, dietary fibres, prebiotics, and a specialized fat blend to support blood glucose management and nutritional requirements among adults with diabetes.
Key Players in Clean-Label Medical Nutrition Bases Market
Key companies profiled include Nestlé Health Science; Abbott; Danone Nutricia; Fresenius Kabi; Arla Foods Ingredients; and FrieslandCampina Ingredients.
- Nestlé Health Science
- Abbott
- Danone Nutricia
- Fresenius Kabi
- Arla Foods Ingredients
- FrieslandCampina Ingredients
Bibliography
- Abbott. (2025, November 13). Abbott launches new and advanced Ensure Diabetes Care, a clinically proven formula to help manage blood sugar.
- Abbott Laboratories. (2026). Abbott Q3 2026 earnings call: Strong execution fuels balanced growth across the portfolio.
- Arla Foods Ingredients. (2026, January 28). Ready-to-stir BLG ingredient offers patient-friendly solution for medical nutrition
- Arla Foods Ingredients. (2026, August 19). Arla Foods Ingredients reduces gas emissions through significant investment in Videbæk.
- Danone S.A. (2026, March 4). Universal registration document 2025
- Danone S.A. (2026, October 28). 2026 third quarter sales: Solid performance in Q3; broad-based growth across categories and geographies.
- FrieslandCampina. (2026). Annual report Royal FrieslandCampina N.V. 2025.
- FrieslandCampina Ingredients. (2026, March 19). FrieslandCampina Ingredients completes strategic expansion of Borculo facility.
- FrieslandCampina Ingredients. (2026, May 5). FrieslandCampina announces major investment programme to accelerate growth in high-value whey proteins.
- FrieslandCampina Ingredients. (2026, October 26). Fi Europe 2026: FrieslandCampina Ingredients showcases new possibilities for protein.
- Nestlé Health Science. (2026, March 30). Nestlé introduces an innovative complete nutritional solution for children with special medical nutrition needs.
- Glanbia plc. (2026, November 4). Third quarter 2026 interim management statement.
Segmentation
Scope of Report

Clean Label Medical Nutrition Bases Taxonomy | Source: Fact.MR
| Items | Values |
|---|---|
| Quantitative Units (2026) | USD 160.0 Million |
| Product Type | Carbohydrate-protein base, Modular clinical nutrition base, Plant-based medical base, Dairy-based medical base, Fiber-fortified base |
| Delivery Form | Liquid, Specialty controlled-release, Tablet and capsule, Powder, Medical device and system |
| Clinical Use | Specialty and rare condition, Long-term management, Nutrition support, Preventive care, Acute care |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East & Africa |
| Countries Covered | Netherlands, United States, Germany, France, United Kingdom, and other countries |
| Key Companies Profiled | Nestlé Health Science, Abbott, Danone Nutricia, Fresenius Kabi, Arla Foods Ingredients, FrieslandCampina Ingredients |
| Additional Attributes | Dollar revenue in the Clean-Label Medical Nutrition Bases Market is segmented by product type (carbohydrate-protein base, modular clinical base, plant-based base, dairy-based base, fiber-fortified base), delivery form, clinical use, and region. |
Source: Fact.MR analysis. Updated Nov 21, 2026
Clean-Label Medical Nutrition Bases Market by Segments
-
Product Type
- Carbohydrate-protein base
- Modular clinical nutrition base
- Plant-based medical base
- Dairy-based medical base
- Fiber-fortified base
-
Delivery Form
- Liquid
- Specialty controlled-release
- Tablet and capsule
- Powder
- Medical device and system
-
Clinical Use
- Specialty and rare condition
- Long-term management
- Nutrition support
- Preventive care
- Acute care
-
Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- North America
Frequently Asked Questions
How big is the global Clean-Label Medical Nutrition Bases Market in 2026?
What will be the size of the Clean-Label Medical Nutrition Bases Market by 2036?
How fast will the Clean-Label Medical Nutrition Bases Market grow during the forecast period?
Which product type segment holds the largest share of the Clean-Label Medical Nutrition Bases Market?
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF